@recklessgran My first week on MJ think I lost 8lb which I put down mostly to water weight and it immediately stopped the daily arthritis like pains I had in my ankles.
@crumbssonmyface Yep my whole adult life seems to have been diet, diet diet as well, I exercised and knew all the theory but would self sabotage eating wise.
Feel at 58 Mounjaro is a miracle and I don’t ever want to revert back to my former eating habits.
I initially thought 9st 10lb was my goal as can’t remember ever weighing less than that, but quite happy at moment weighing 9st 5lb. Feel like it gives me a bit of a cushion in case I put a few pound on.
As I have reduced to 2.5mg this week have been able to eat the additional 100 calories a day no problem, though continuing not to eat any ultra processed food and find eating high protein really fills me up. Enjoying my weight sessions but haven’t noticed a difference in strength etc yet in eating more.
Think I have been too obsessed with the scales as when I have had big weight losses I am made up but some of that will have been muscle which is not good.
One of the reasons I started MJ was a couple of the menopause health podcasts I listened to said it had been really beneficial for those who struggled to lose weight but they all really stress the importance of weight training and protein as they are concerned with sarcopenia ie muscle loss.
A wake up call to me was that the only time our bodies would normally lose the amount of muscle most people do on MJ is if they have cancer so really important to start preserving it. And it’s never too late to start.
Also the below from the Lancet -
The importance of skeletal muscle mass is increasingly being recognised in the medical field.1 The crucial roles of skeletal muscle have come to the forefront of public attention due to data on the use of GLP-1 receptor agonists, which are effective for weight loss, but can cause substantial muscle loss. Studies suggest muscle loss with these medications (as indicated by decreases in fat-free mass [FFM]) ranges from 25% to 39% of the total weight lost over 36–72 weeks.2 This substantial muscle loss can be largely attributed to the magnitude of weight loss, rather than by an independent effect of GLP-1 receptor agonists, although this hypothesis must be tested. By comparison, non-pharmacological caloric restriction studies with smaller magnitudes of weight loss result in 10–30% FFM losses.3 In context, on an annual basis, the decline in muscle mass with GLP-1 receptor agonists is several times greater than what would be expected from age-related muscle loss (0·8% per year based on 8% muscle loss per decade from ages 40–70 years). Dismissing the importance of muscle loss can create a disconnect between patients' increased awareness of muscle and the role it plays in health, and clinicians who downplay these concerns, affecting adherence to and the development of optimised treatment plans.